In the present experimental and clinical study, by employing proteomic analysis in both neonatal mice and preterm infants, we identified LCN2 as a promising marker for preterm infection/inflammation associated with cerebrovascular alterations and neuroinflammation. This evidence concerns the gene LCN2 and infection.